Key Recommendations from the 54th GST Council Meeting: Relief Measures and Future Planning
On September 9, 2024, the 54th meeting of the GST Council, chaired by Union Minister for Finance & Corporate Affairs, Smt. Nirmala Sitharaman, brought forth significant recommendations on GST rates, tax exemptions, and measures to streamline compliance. This meeting, held in New Delhi, saw the participation of Union Minister of State for Finance, Shri Pankaj Chaudhary, as well as Chief Ministers and Finance Ministers from various states and union territories. The Council’s deliberations addressed pressing issues such as life and health insurance GST, research services, cancer drug tax relief, and future compliance initiatives.
Key Recommendations from the 54th GST Council Meeting
Group of Ministers (GoM) on Life and Health Insurance GST
The Council has recommended that the existing Group of Ministers (GoM) on Rate Rationalisation also examine the matter of GST related to life and health insurance. The GoM is tasked with submitting its comprehensive report by the end of October 2024. This step reflects the Council’s commitment to rationalising GST rates in sectors crucial to public welfare.
Formation of GoM on Compensation Cess
The Council recommended the formation of a new Group of Ministers to study the future of the compensation cess, a vital component in offsetting revenue shortfalls for states. This GoM will explore the long-term sustainability of the compensation mechanism and its role in the post-GST implementation period.
Exemption for Research and Development Services
In a significant move to boost innovation and research, the GST Council recommended exempting the supply of research and development (R&D) services. This exemption applies to services provided by government entities, research associations, universities, colleges, or other institutions notified under Section 35 of the Income Tax Act, 1961. Whether funded by government or private grants, this decision encourages academic and scientific research without the burden of GST.
Reduction in GST Rates on Cancer Drugs
In a major relief to cancer patients, the Council recommended a reduction in GST rates on three cancer drugs: Trastuzumab Deruxtecan, Osimertinib, and Durvalumab, from 12% to 5%. This reduction aligns with the government’s objective of making life-saving drugs more affordable and accessible.
Pilot Rollout for B2C e-Invoicing
To streamline compliance and further digitise GST operations, the Council recommended rolling out a pilot for B2C (business-to-consumer) e-invoicing. This pilot initiative is expected to enhance transparency and reduce tax evasion in retail transactions by capturing real-time data.
The 54th GST Council meeting made substantial progress in addressing both immediate tax relief measures and long-term fiscal policies. By focusing on key sectors like healthcare, insurance, and research, the Council aims to foster a more inclusive, transparent, and efficient tax regime. The formation of new Groups of Ministers to study compensation cess and insurance-related GST further demonstrates the Council’s proactive approach to ensure that the GST framework evolves to meet India’s dynamic economic needs.
These recommendations are expected to bring significant relief to businesses, healthcare providers, and consumers while promoting fair competition and boosting economic growth across sectors.
